KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $3.1 billion.

  • Medtronic's Cost of Revenue rose 390.36% to $3.1 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $12.0 billion, marking a year-over-year increase of 394.52%. This contributed to the annual value of $11.6 billion for FY2025, which is 370.9% up from last year.
  • Medtronic's Cost of Revenue amounted to $3.1 billion in Q4 2025, which was up 390.36% from $3.0 billion recorded in Q3 2025.
  • In the past 5 years, Medtronic's Cost of Revenue registered a high of $3.1 billion during Q2 2025, and its lowest value of $2.5 billion during Q1 2022.
  • Over the past 5 years, Medtronic's median Cost of Revenue value was $2.7 billion (recorded in 2023), while the average stood at $2.8 billion.
  • Within the past 5 years, the most significant YoY rise in Medtronic's Cost of Revenue was 1718.2% (2021), while the steepest drop was 768.95% (2021).
  • Over the past 5 years, Medtronic's Cost of Revenue (Quarter) stood at $2.5 billion in 2021, then increased by 1.52% to $2.5 billion in 2022, then rose by 8.92% to $2.8 billion in 2023, then increased by 6.7% to $2.9 billion in 2024, then increased by 3.9% to $3.1 billion in 2025.
  • Its last three reported values are $3.1 billion in Q4 2025, $3.0 billion for Q3 2025, and $3.1 billion during Q2 2025.